Brontictuzumab Biosimilar – Anti-NOTCH1 mAb – Research Grade

Reference:
Product nameBrontictuzumab Biosimilar - Anti-NOTCH1 mAb - Research Grade
SourceCAS 1447814-75-6
SpeciesHumanized
Expression systemMammalian cells
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
ApplicationsELISA,WB
Aliases /SynonymsBrontictuzumab,OMP-52M51,NOTCH1,anti-NOTCH1
ReferencePX-TA1347
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG2-lambda
ClonalityMonoclonal Antibody

Description of Brontictuzumab Biosimilar - Anti-NOTCH1 mAb - Research Grade

General information on Anti-NOTCH1[Homo sapiens] (Brontictuzumab) Monoclonal Antibody

Brontictuzumab has been investigated in the treatment of adenoid cystic carcinoma, relapsed or refractory solid tumors, and lymphoid malignancies.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Brontictuzumab Biosimilar – Anti-NOTCH1 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

Stable Isotope Labelled Brontictuzumab Biosimilar – Anti-NOTCH1 mAb – Research Grade
SIL

Stable Isotope Labelled Brontictuzumab Biosimilar – Anti-NOTCH1 mAb – Research Grade

PX-TA1347-SIL 15000€

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.






    Cart (0 Items)

    Your cart is currently empty.

    View Products